Ardigen at ASCO18

Topic:

Between June 1st and 5th our representation joined nearly 40 thousand people attending American Society of Clinical Oncology Annual Meeting in Chicago. This year’s ASCO theme was “Delivering Discoveries: Expanding the Reach of Precision Medicine”.

During those five days we attended sessions, talked to speakers and exhibitors, discussed posters and gathered knowledge especially focusing on immuno-oncology. Among the inspiring topics we were able to touch were current clinical advances of various biomarker strategies for companion diagnostics, exciting clinical trials results, and future directions of precision medicine in oncology.

Please have a look at our blog to read more about our impressions from the meeting.

You might be also interested in:

Can AI Stop the Cost Spiral in Drug Discovery? Summary of Our Expert Talk at BioTech X 2025
Your monthly AI in biotech digest – October
Abstract visualization of AI-driven analysis of patient data, representing precision medicine and responder identification.
Precision Trials: Using AI to Identify Responders
Poster: Safer pHLA-Targeted Immunotherapies Through AI and Computational Immunology

Contact

Ready to transform drug discovery?

Discover how one of the top AI CROs in the world, can be your trusted partner in revolutionizing drug discovery through AI.

Contact us today to learn more about our tailored solutions for empowering your drug development journey.

Send us a message and we will contact you back within 48 hours.

Newsletter

Become an insider

Be the first to know about Ardigen’s latest news and get access to our publications, webinars and more!